enVVeno Medical Reports Net Losses of $23.5 Million in its 2023 Financial Year
Friday, 1 March 2024, 15:25
enVVeno Medical FY Results
enVVeno Medical (NVNO) reported net losses of $23.5 million in 2023, highlighting a decline from the previous year.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.